Evidence map›Paper›PMID 35784322›Full record

ArticleFrontiers in immunology2022

The H

David Alexander Christian Messerer, Holger Gaessler, Andrea Hoffmann, Michael Gröger, Kathrin Benz, Aileen Huhn, Felix Hezel, Enrico Calzia, Peter Radermacher, Thomas Datzmann

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Frontiers in immunology · 2023
    Article
  5. Review
  6. HBiomolecules · 2022
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

David Alexander Christian MessererInstitute for Anesthesiologic Pathophysiology and Process Engineering, Ulm University, Ulm, Germany.
Holger GaesslerDepartment of Anesthesiology, Intensive Care Medicine, Emergency Medicine and Pain Therapy, German Armed Forces Hospital Ulm, Ulm, Germany.
Andrea HoffmannInstitute for Anesthesiologic Pathophysiology and Process Engineering, Ulm University, Ulm, Germany.
Michael GrögerInstitute for Anesthesiologic Pathophysiology and Process Engineering, Ulm University, Ulm, Germany.
Kathrin BenzInstitute for Anesthesiologic Pathophysiology and Process Engineering, Ulm University, Ulm, Germany.
Aileen HuhnInstitute for Anesthesiologic Pathophysiology and Process Engineering, Ulm University, Ulm, Germany.
Felix HezelInstitute for Anesthesiologic Pathophysiology and Process Engineering, Ulm University, Ulm, Germany.
Enrico CalziaInstitute for Anesthesiologic Pathophysiology and Process Engineering, Ulm University, Ulm, Germany.
Peter RadermacherInstitute for Anesthesiologic Pathophysiology and Process Engineering, Ulm University, Ulm, Germany.
Thomas DatzmannInstitute for Anesthesiologic Pathophysiology and Process Engineering, Ulm University, Ulm, Germany.
Universität Ulm · DEUniversitätsklinikum Erlangen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously demonstrated marked lung-protective properties of the H

Indexed as

Shock, HemorrhagicAnimalsInflammationLungProspective StudiesSwineThiosulfatessodium thiosulfateThiosulfatesanimal modelgaseous mediatorhemorrhagehydrogen sulfidephysical injuriessystemic inflammation

Identifiers

PMID35784322
PMCPMC9243230
OpenAlexW4282979264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.